ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Deep Value Dividend Portfolio Series 43

Deep Value Dividend Portfolio Series 43 (FAZMJX)

0.00
0.00
(0.00%)
Closed 27 September 6:00AM
0.00
0.00
( 0.00% )

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
-
Bid
-
Offer
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

FAZMJX Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000FU
40000000FU
120000000FU
260000000FU
520000000FU
1560000000FU
2600000000FU

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ONCOOnconetix Inc
US$ 5.99
(78.52%)
8.16M
CNEYCN Energy Group Inc
US$ 0.945
(62.96%)
21.93M
XPONExpion360 Inc
US$ 0.09495
(47.44%)
57.81M
ESTAEstablishment Labs Holdings Inc
US$ 52.89
(28.39%)
51.07k
RGFReal Good Food Company Inc
US$ 0.47
(27.03%)
4.09M
HLPHongil Group Inc
US$ 0.905
(-49.86%)
10
LELands End Inc
US$ 13.84
(-17.81%)
516
NVNOenVVeno Medical Corporation
US$ 3.71
(-17.56%)
90.71k
AYTUAYTU BioPharma Inc
US$ 2.39
(-16.11%)
3.17k
MNTSMomentus Inc
US$ 0.4501
(-16.03%)
270.34k
XPONExpion360 Inc
US$ 0.09495
(47.44%)
57.81M
DUOFangDD Network Group Ltd
US$ 1.34
(25.23%)
22.97M
CNEYCN Energy Group Inc
US$ 0.945
(62.96%)
21.93M
CDIOCardio Diagnostics Holdings Inc
US$ 0.285
(14.00%)
11.61M
ONCOOnconetix Inc
US$ 5.99
(78.52%)
8.16M

Discussion

View Full Feed
Risk Risk 5 minutes ago
This is awesome. Thanks TJ. Need a lot of patience.
AFFU
nidan7500 nidan7500 5 minutes ago
georgejjiUS FDA approves Bristol Myers' schizophrenia drug

FDA approval for new type of schizophrenia treatment

ristol prices drug at $1,850 a month

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-bristol-myers-schizophrenia-dr
AVXL
RobotDroid RobotDroid 5 minutes ago
Another wrong opinion. Too funny how the cult looks at other companies data and thinks it applies to nwbo. It doesn't, no other compnay has the worst, inept mute mismanagement clown show in history.
NWBO
Risk Risk 6 minutes ago
TJ that’s better dream :)) OS dream big :))
AFFU
Wingsjr Wingsjr 6 minutes ago
Thx, brother. 👍
FNMA
Golden Cross Golden Cross 6 minutes ago
$XXII New Customer for 22nd Century's Internally Owned Moonlight Brand Could Increase Factory Volumes by More Than 30% When Fully Scaled, Improve Gross Profit Profile
https://www.newsfilecorp.com/release/224193/22nd-Century-Announces-New-Branded-Products-Order-with-Customer-for-Southeast-Asi
XXII
GetSeriousOK GetSeriousOK 7 minutes ago
Call her then.

And don't accept "we'll release a PR when it's appropriate" for an answer.

Personally, I wouldn't believe anything she told you over the phone, but that's just my experience with biotech CEO phone calls. Whatever she says, tell her "Put that in writing.
BIEL
Golden Cross Golden Cross 7 minutes ago
$XXII New Customer for 22nd Century's Internally Owned Moonlight Brand Could Increase Factory Volumes by More Than 30% When Fully Scaled, Improve Gross Profit Profile
https://www.newsfilecorp.com/release/224193/22nd-Century-Announces-New-Branded-Products-Order-with-Customer-for-Southeast-Asi
XXII
weedtrader420 weedtrader420 8 minutes ago
XRP✊😎 Lynyrd Skynyrd SIMPLE MAN $1 TARGET
XRPUSD
MFranny MFranny 8 minutes ago
That's where, at the very least, Steven Walker should have been present. But he wasn't...
SHMP
GetSeriousOK GetSeriousOK 9 minutes ago
Sorry, the patents expired due to non-payment of maintenance fees.

"Extended to 2029" refers to the Patent Term Restoration (PTR) extension. IF Whelan had paid the maintenance fees, the patents would be active until 2029. Without that extension they would have expired in 2023, twenty
BIEL
manibiotech manibiotech 9 minutes ago
In that case they will have to take personal responsibility and be held accountable . Current strategy transfers 100% of responsibility and blame on someone else . So what’s the incentive to change ?
NWBO
zj3001 zj3001 9 minutes ago
$RNAZ everyone so focused on a price per share, but no one ever talks about market cap. Imagine Transcode getting a $50-200m upfront payment to partner with Big Pharma. What do you think that makes the value of the company?

What if they get fda fast track approval?

It
RNAZ
Alexulf Alexulf 9 minutes ago
We continue the climb up!

Strong news do the trick :-)

https://aitx.ai/
AITX
MetaMonster MetaMonster 9 minutes ago
Ceo Mark White is in rehab for drug addiction
FOXO
FeMike FeMike 10 minutes ago
That's just a guess, and probably wrong.
You realize you are an absolute moron, right? 3 months ago after the ASM, when I said we hadn't gotten an RFI yet and were still in phase 1, you told me that was "100% not true". When i asked you to clarify, you said:
We are not in phase 1. Th
ASM
James56 James56 10 minutes ago
Soon.
MDCE
2020trader 2020trader 10 minutes ago
that would be a wasted call...lol
CLNV
1vman 1vman 10 minutes ago
*****Wowzah🟥🟥🟥🟥 Power2theGMEshorters/brilliant, interest has faded big time here

ENOUGH SAID
GME
arachnodude arachnodude 10 minutes ago
Consider demand influences the rate at which they produce, but the capacity reflects what the facility is capable of producing under optimal conditions, regardless of how much is currently being ordered or sold.
KBLB
kid70 kid70 10 minutes ago
Hopefully, we can beat yesterday volume. Lol
UBQU
Deano361 Deano361 11 minutes ago
Now from 100 to 500m?
FUNR